Vijaya Diagnostic Centre Limited CC-May26.pdf · 2026-05-08
Yes. Hi, sir. Thank you for giving me the opportunity and congratulations on a good set of numbers. So, my first question would be like in Q4, the EBITDA margin came in 43.5%, which is 380 bps Y -o-Y expansion. But when you strip out the operating leverage on the fixed cost base, the other expense line grew 21% in Y -o-Y in Q4. So what specific cost levers drive this margin outperformance? Can you throw some color on that?
Okay. Great, sir. And sir, the last question on the revenue per test, which has been a jump by 4.3%. So even though your pathology, radiology mix is quite similar in FY'25. So is it because of wellness share increase or what's the reason?